Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- Long-term benefits of ADHD drugs in kids are uncertain - ConsumerReports.org (blog)
- Long-term benefits of ADHD drugs in kids are uncertainConsumerReports
- Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises ... - MarketWatch (press release)
- Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises
- Retail prices of 1000 medicines to fall under new reimbursement list - Pharma Poland News (subscription)
- Pharma Poland News (subscription)Retail prices of 1000 medicines to fall under new reimbursement listPharma Poland News (subscription)Also, it again includes atomoxetine as indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged six and older and teens
- 不專心坐不住 恐患注意力不足過動症 - yam天空新聞
- 不專心坐不住 恐患注意力不足過動症yam天空新聞根據衛生署指出，目前核准用以治療ADHD的藥物是（一）中樞神經興奮劑：Methylphenidate，MPH（短效型MPH，Ritalin；長效型MPH，Concerta），國際上已使用於治療ADHD超過50年了，衛生署也核准MPH治療ADHD長達數十年了；（二）非中樞神經興奮劑：Atomoxetine（思銳）。and more »
